ABSTRACT
INTRODUCTION
Mesenchymal stem cells (MSCs) reside in most adult tissues where they contribute to normal tissue turnover and repair. In addition to direct capacity to differentiate into multiple cell lineages e.g. osteoblasts, chondrocytes, tenocytes and myocytes (1, 2), MSCs may also have trophic and regulatory functions. The therapeutic potential of MSCs is unquestionable. MSC-based therapies have been reported in different clinical applications, including treatment of bone fractures and nerve injuries as well as in myocardial infarction (for review, see 3, 4). However, the final breakthrough in clinical use is still missing, mainly due to obstacles in their large-scale commercial implementation (5).
There is increasing evidence that a monotherapy based on the use of MSCs alone may not be the answer in all situations. For example, porous biomaterials can successfully be seeded with culture expanded MSCs in vitro, but long term survival after in vivo implantation fails due to lack of oxygen and nutrient supply in the inner parts of the non-vascularized implants (6). Angiogenesis is decisive for a successful outcome in all types of tissue healing and regeneration. New solutions for enhancing vascularization of surgically reconstructed tissues could significantly improve the conditions for many patients (7). An emerging concept is the use of MSCs together with endothelial cells or their progenitors for therapeutic solutions.
One of many regulatory roles of MSCs is the maintenance of adult and fetal hemopoiesis (8). MSCs together with MSC-originated cells regulate the survival, self-renewal, migration and differentiation of hematopoietic cells in the bone marrow through their wide capacity to produce different growth factors (9). Adult human MSCs are able to produce the essential vasculogenic factor; vascular endothelial growth factor (VEGF) in response to different cytokines, such as tumor necrosis factor-α (TNF-α) (10) . When therapeutically injected, human MSCs have also shown to promote arteriogenesis of ischemic myocardium (11) and the results of most clinical studies are promising (12) . A mechanistic explanation for these results might be capacity of MSCs to rescue cardiomyoblasts from cell death, which has recently been demonstrated in an in vitro ischemia model (13) .
It has been reported that the peripheral blood mononuclear cell (MNCs) population contains endothelial progenitor cells (EPCs), which are able to differentiate into blood vessel endothelial cells (ECs) (14) . EPCs have been identified among CD34+ (15, 16) and CD14+ (17) MNCs. EPCs are important cells in postnatal vasculogenesis (18) and neovascularization (18, 19) . Evidence suggests that EPCs are normally sparse in the peripheral circulation but are mobilized from bone marrow in different stress situations, such as myocardial or hind limb ischemia (19, 20) .
For tissue engineering it is essential to find an optimal EC source for angiogenesis without triggering any immunoreactions in the body. Autologous peripheral MNCs seem to be ideal for these purposes. However, widely used methods for in vitro endothelial differentiation (21, 22) require several inducing factors to create special conditions for endothelialization of a scaffold. Current protocols are both time consuming and expensive, and many of the required supplements are not ideal for implantation in human patients. Therefore development of more straightforward protocols, free of xenogenic supplements, is essential for new reconstructive solutions to reach the clinic.
In this study, the interaction between human MSCs and MNCs was investigated as a new solution for in vitro endothelialization in an approach to both simplify and enhance vascularization.
MATERIALS AND METHODS

CELL ISOLATION AND CULTURE
Human MSCs were isolated from single aspirates of 5-6 ml iliac bone marrow from three different donors under spinal anesthesia, prior to orthopaedic surgery. Bone marrow aspirates were mixed with α-minimum essential medium (α-MEM; Gibco, UK) containing 100 IU/ml of penicillin and 100 µg/ml of streptomycin (Gibco) and 20 IU/ml of heparin (Heparin Leo; LEO Pharma A/S, Ballerup, Denmark). MNCs were isolated by density gradient centrifugation (Ficoll Paque Plus, Amersham Pharmacia, UK). Cells were seeded at 1 × 10 6 cells in a 25 cm 2 tissue culture flasks (Gibco) and cultured in α-MEM containing 10% fetal bovine serum (FBS) and antibiotics, hereafter referred to as basal medium. After culturing for 48 hours, non-adherent cells were discarded and medium was thereafter changed every fourth day. Upon confluency, cells were harvested using trypsin/EDTA (Gibco), counted and re-plated at 1000 cells/cm 2 . Passages 3-6 were used for the experiments. Blood samples were taken from a healthy volunteer and MNCs were isolated by density gradient centrifugation. After five days, 5 × 10 4 MNCs/cm 2 were added to the cultures containing MSCs except for the controls including plain MSCs. Three to six parallel samples were cultured from each MSC donor (n = 3) for each time point investigated (5, 10, 15, 20 days). Cells were cultured in basal medium and half of the media was changed every 4-5 days. Before starting the experiments, pilot studies were performed to optimize the culture conditions, including culturing time and cell densities. Cultures were constantly microscopically monitored and the criteria were the tube-like structure formation.
IMMUNOHISTOCHEMISTRy FOR PECAM-1 AND ENDOGLIN After 5, 10, 15 and 20 days of culture, cells were fixed in 2% paraformaldehyde (PFA). Cultures were blocked with 3% bovine serum albumin (BSA) for 1h at room temperature (RT), washed with PBS and incubated for 1h at RT with rabbit anti-human PECAM-1 (CD31) antibody (1:50) (Santa Cruz Biotechnology, Santa Cruz California, USA) and mouse anti-human endoglin (CD105) antibody (1:20) (DakoCytomation Inc, Denmark). Secondary antibodies included goat anti-rabbit biotinylated antibody (Bio-Rad Laboratories, Hercules California, USA) and biotin-conjugated polyclonal rabbit anti-mouse antibody (DakoCytomation) (1:200 for both). Samples with omitted primary antibodies were used as negative controls. PECAM-1-staining was detected by Vectastain ABC kit (Vector laboratories, UK) and cultures with biotin-conjugated secondary antibodies for endoglin were detected with Streptavidin-HRP-conjugate (DakoCytomation) (1:400) and DAB (diaminobenzidine, 0.52 mg/ml; Sigma-Aldrich, St. Louis) staining. Samples were examined and photographed under light mic roscope (Leitz Aristoplan, Wezlar, Germany).
cDNA SyNTHESIS AND qUANTITATIVE REAL TIME RT-PCR For analysis of mRNA expression levels of vascular endothelial growth factor receptors 1 and 2 (VEGFR1 and VEGFR2), MSC-MNC co-cultures as well as plain MSCs (passages 3-4) from all three donors were cultured in 10 cm 2 culture dishes. Total RNA was isolated at 5, 10, 15 and 20 days according to manufacturer's instructions (Sigma GenElute TM Mammalian Total RNA kit). One microgram of total RNA was treated with 5 units of DNase I (Roche, Indianapolis, USA) and subjected to first-strand cDNA synthesis using MuMLV-H(-) reverse transcriptase (Promega, UK; 200 units) and random hexamer primers (Promega, 0,5 µg). PCR reaction was performed in duplicates as described previously (23) except that primer and probe concentrations used in VEGFR1 and VEGFR2 PCR were 200 nM and 100 nM, respectively. Data analysis was performed as described previously (23) except, that target gene Ct-values were compared to GAPDH Ct-values. VEGFR1 and VEG-FR2 probes were from Universal Probelibrary (Roche). The following primers and probes were used: VEGFR1 5´ATG CCA GCA AGT GGG AGTT, 3´CAA AAG CCC CTC TTC CAA GT, VEGFR1-probe CTG GGC AA (Probe #61),  VEGFR2 5´TGA ACT AAA TGT GGG GA TTG ACT, 3´CGG  TTT ACA AGT TTC TTA TGC TGA, VEGFR2-probe ACT  GGG AA (Probe #48) , GAPDH 5´ACC AGG CGC CCA ATA CGA CCA A, 3´GTT CGA ACA GTC AGC CGC ATC and GAPDH-probe GGA ATT TGC CAT GGG TGG A.
THREE-DIMENSIONAL MSC-MNC CO-CULTURES AND DEMONSTRATION OF TARTRATE-RESISTANT ACID PHOSPHATASE ExPRESSION OF ENDOTHELIAL-LIKE CELLS
Three dimensional (3D) co-cultures of MSCs and MNCs were established by culturing cells in bovine denatured type I collagen sponge (Spongostan, Johnson & Johnson, UK), which is widely used in clinical applications. Collagen-sponge was cut in 5 mm × 5 mm pieces and incubated in basal medium in 24-well plates for 30 min at +37 °C. 10 000 passage 6 MSCs from one donor in 40 µl medium were added to the center of sponge pieces and cultured in basal medium. After 3 days, 100 000 MNCs were added except for the controls. After 15 and 20 days, the 3D cocultures were fixed with 2% PFA. Co-cultures were stained for tartrate-resistant acid phosphate (TRACP) using a Leukocyte acid phosphatase kit (Sigma-Aldrich) to identify monocyte-derived cells. TRACP is normally expressed by cells of macrophage/osteoclast lineage (24) .
STATISTICAL PROCEDURES
In order to reduce experiment-to-experiment variations from quantitative real-time PCR measurements, data from each experiment was normalized by dividing all values from each experiment with the highest value of that experiment. Data is presented as mean ± SD. After normalization, data from the three separate experiments were pooled and tested for normal distribution and equal variances using Kolmigorov-Smirnov and Levene's test, respectively. Differences in expression levels of VEGFR1 and VEGFR2 were compared between MSC-MNC co-cultures and MSCs cultured alone, using paired t-test.
RESULTS
MSC-MNC CO-CULTURE
In human MSC and MNC co-cultures, the MNC-population attached over the MSC-layer after 5 days of co-culture. Cells became elongated and started to migrate and form tube-like structures after one week of culture. After two weeks, part of the cells in the middle of the cord became rounded and organized into cobblestone structures, while cells in the periphery of the cord were arranged in a capillary-like pattern ( Fig. 1A and B) . Vessel-like formations were observed and after four weeks of co-culture, 3D structures of approximately 1 cm in length could be seen with the naked eye. Formation of vessel-like structures in the co-cultures was most efficient when MSCs from passage 5 or earlier were used. While optimizing the culture conditions in pilot studies, we used MNC samples from three donors and observed a similar tube formation in all cases. In following parts of the study, we used only one MNC donor to reduce the effect of donor variability. 
IMMUNOHISTOCHEMISTRy FOR PECAM-1 AND ENDOGLIN
The expression of PECAM-1 became stronger with longer culture periods. At day 10, elongated PECAM-1 expressing cells were clearly seen (Fig. 2B) . Finally at day 20, PECAM-1-positive cord-like structures were observed (1-2/well) (Fig. 2D ). There were no PECAM-1-positive cells discovered in the MSCcultures without MNCs at any time point (Fig. 2E) . In the cocultures, the expression of endoglin was similar to that of PE-CAM-1. Cells started to express endoglin between days 5 and 10. At day 10, migrating, elongated endoglin-positive cells were observed in the co-cultures (Fig.  2G) . MSCs cultured without MNCs showed a qualitatively much weaker staining for endoglin compared to co-cultures (Fig. 2J) . No staining was observed in any of the negative controls.
qUANTITATIVE REAL-TIME PCR quantitative RT-PCR was used to measure the expression levels of VEGFR1 and VEGFR2 (Fig. 3) . Expression levels in cultures were analyzed at 5, 10, 15 or 20 days from all three donors. mRNA expression levels for both VEGFR1 and VEGFR2 were generally low. In the co-cultures, VEGFR1 was up-regulated at 10 days, and expression levels increased over time (Fig. 3A) . At 15 and 20 days, the expression level in co-cultures was significantly higher compared to MSC control cultures. The expression level of VEGFR2 mRNA was less than 0.5% of the control (GAPDH) in both co-cultures and control cultures at all time points (Fig. 3B ).
3D MSC-MNC CO-CULTURES AND DEMONSTRATION OF TRACP ExPRESSION OF ENDOTHELIAL-LIKE CELLS
The 3D co-cultures of MSCs and MNCs in bovine collagen sponge showed that tubeforming cells were able to attach to collagen fibers. After 15 and 20 days, cultures were stained for TRACP to locate the monocyte-derived cells. TRACPpositive longitudinal cells were detected evenly spread throughout the sponge (Fig. 4) . MNCs that could be utilized to induce and enhance angiogenesis in vivo. MSCs seeded in a tissue engineered scaffolds are not vital long enough to induce vascularization by interacting with circulating MNCs in vivo. Therefore, a multilineage cell therapy may give a new perspective when developing tissue engineering concepts.
To demonstrate the EC differentiation, MSCs and MNCs were co-cultured and studied at different time points. Cultures of MSCs alone were used as a negative control. Several attempts were made to culture MNCs alone as an additional control group, but it seems that without added growth factors such as macrophage-colony stimulating factor, these cells are not able to proliferate in culture and eventually they underwent apoptosis.
In the co-cultures, the expression of PECAM-1 and endoglin increased along the culture periods. PE-CAM-1 is an integral membrane glycoprotein belonging to the immunoglobulin superfamily and it is an important molecule for vascular cell adhesion, involved especially in endothelial cell-cell adhesion (25) . Endoglin is a receptor for transforming growth factor-β (TGF-β), which induces EC proliferation (26) in angiogenesis. It is highly expressed on human vascular ECs, especially in proliferating ECs. The expression profiles of PECAM-1 and endoglin indicate the progress of EC differentiation and adhesion when the cells migrated and formed vessel-like structures in co-cultures.
VEGF receptors 1 and 2 are receptor tyrosine kinases, which are expressed on the cell surface of most blood ECs. In co-cultures, the mRNA expression of VEGFR1 was significantly up-regulated compared to MSC control cultures, while the mRNA expression of VEGFR2 was very low (< 0.5%). The role of VEGFR1 on the EC surface is considered as a "decoy" for not having an effective mitogenic signal in ECs (27) . Instead, it is needed for the migration of the monocytes in response to VEGF (26) , which probably explains the earlier expression of VEGFR1 in the co-cultures. VEGFR2 is considered as a major mediator of EC mitogenesis and survival (27) .
One limitation in our study is the use of only one donor to obtain MNCs. However, in pilot studies we sampled MNCs from two other donors and detected a similar tube-like structure formation. The rationale for choosing a single donor for following experiments was to reduce the effects of donor variation and thereby fix one of the variables. If several MNC donors had been used in the experiments, more variation in the marker levels would probably have been observed.
MNCs cultured in the presence of commercial medium, such as endothelial cell basal medium (EGM-2, Clonetics Inc., San Diego, California, US) (20, 21) would have been a good control for this study. EGM-2 contains differentiation factors, such as hydrocortisone, bovine brain extract and human epidermal growth factor. In the protocol, MNCs are isolated from peripheral blood, plated in cell culture dishes coated with fibronectin or type I collagen and cultured for a certain period of time in EGM-2. When comparing the protocols, our co-culture system is much easier to perform because no additional growth factors or extracellular matrix protein-coatings are needed for proper EC differentiation. In addition, our co-cultures also included the MSC population which contributes to additional benefits in tissue engineering applications.
It has been shown that MSCs themselves are able to differentiate into ECs (28, 29) . In our study, we observed how a non-adherent MNC population in the co-cultures became adherent, took a spindle shape and migrated to form tube-like structures. In addition, we stained the co-cultures for TRACP. Spindleshaped cells were TRACP positive, indicating that ECs present in the cultures were of MNC-origin instead of MSC-origin. TRACP is shown to be expressed by cells of monocytic lineage (30) . Recently it has been shown that TRACP is released by monocytes but can be endocytosed by osteoblastic cells in during bone turnover and that osteoblastic cells would express low doses of TRACP-like activity (31) . However, we found no evidence that MSCs themselves could produce and release TRACP. A major limitation of our 3D co-culture experiment is the fact that it was performed using single donor for both MSCs as well as for MNCs. In addition, the culture conditions were not the most optimal because the passage number of MSCs was relatively high. These limitations may contribute to our results and thereby weaken the final conclusion on the true characteristics of TRACP-positive cells. To better identify these cells, some earlier markers for MNCs such as CD14 and CD11b (32) could also have been measured. However, our data suggests that the influence of MSCs on angiogenesis might be due to direct paracrine effects on circulating EPCs. Indeed, even though it has been shown that MSCs improve the function of ischemic heart muscle mainly by promoting angiogenesis through cell plasticity (28, 29) , there is also evidence suggesting that the main action might be paracrine (33) .
In the future, it is essential to more closely study the mechanisms behind the EC differentiation. Based on our results, one can only hypothesize the potential factors responsible for interactions between MSCs and MNCs. However, it has been shown that MSCs are able to produce a variety of growth factors needed for endothelial cell differentiation (10) . We suppose that there are soluble factor(s) produced by MNCs that induce MSCs to produce the angiogenic factors. It is possible that MSCs provide a nutritious environment with survival factors for EPCs, but also the essential key components for promoting angiogenesis. The next step includes culturing MSCs and MNCs separately but changing the medium between these two cell populations. This will demonstrate whether it is physical contact or soluble factors that are needed for endothelial cell differentiation, and the role of each cell type in the interaction leading to vessel-like structure formation. Co-cultures will also be conducted using culture dishes that prevent physical contact. These experiments will give a reference which cell type is responsible for EC differentiation.
Despite the lack of data behind the interaction mechanisms between human MSCs and MNCs, one cannot rule out the novel finding that tube-forming endothelial cells are assembled in co-cultures. Our data suggests paracrine mechanisms by which MSCs induce angiogenesis in vivo. The finding highlights the importance of cell-cell interactions when developing new tissue engineering concepts for repair, replacement, or regeneration of mesenchymal tissues such as bone, cartilage and tendon.
